Fabrizio Nannipieri

441 total citations
23 papers, 270 citations indexed

About

Fabrizio Nannipieri is a scholar working on Pathology and Forensic Medicine, Oncology and Orthopedics and Sports Medicine. According to data from OpenAlex, Fabrizio Nannipieri has authored 23 papers receiving a total of 270 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pathology and Forensic Medicine, 5 papers in Oncology and 5 papers in Orthopedics and Sports Medicine. Recurrent topics in Fabrizio Nannipieri's work include Vitamin D Research Studies (7 papers), Dermatology and Skin Diseases (4 papers) and Bone health and treatments (3 papers). Fabrizio Nannipieri is often cited by papers focused on Vitamin D Research Studies (7 papers), Dermatology and Skin Diseases (4 papers) and Bone health and treatments (3 papers). Fabrizio Nannipieri collaborates with scholars based in Italy, Austria and Switzerland. Fabrizio Nannipieri's co-authors include Massimo Locatelli, Andrea Giustina, Stefano Frara, Luigi di Filippo, V. Braga, Patrizia Rovere‐Querini, S. Ortolani, Paolo Filipponi, E Palummeri and Maurizio Bevilacqua and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Clinical Endocrinology & Metabolism and International Journal of Molecular Sciences.

In The Last Decade

Fabrizio Nannipieri

20 papers receiving 266 citations

Peers

Countries citing papers authored by Fabrizio Nannipieri

Since Specialization

Citations

This map shows the geographic impact of Fabrizio Nannipieri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabrizio Nannipieri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabrizio Nannipieri more than expected).

Fields of papers citing papers by Fabrizio Nannipieri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabrizio Nannipieri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabrizio Nannipieri. The network helps show where Fabrizio Nannipieri may publish in the future.

Co-authorship network of co-authors of Fabrizio Nannipieri

This figure shows the co-authorship network connecting the top 25 collaborators of Fabrizio Nannipieri. A scholar is included among the top collaborators of Fabrizio Nannipieri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabrizio Nannipieri. Fabrizio Nannipieri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Non-Skeletal Roles of Vitamin D in Skin, Gut, and Cardiovascular Disease: Focus on Epithelial Barrier Function and Immune Regulation in Chronic Disease 2025 ·International Journal of Molecular Sciences ·Teresa Grieco, Giovanni Paolino, Elisa Moliterni, Camilla Chello, Alvise Sernicola, Maria Luisa Brandi, Colin Gerard Egan, Mariangela Morelli, Fabrizio Nannipieri, (unknown), (unknown), (unknown), (unknown), (unknown), Camilla Calvieri, Giovanni Pellacani, Stefano Calvieri	0
2	Transcriptomic Profiling of Lesional and Perilesional Skin in Atopic Dermatitis Suggests Barrier Dysfunction, Inflammatory Activation, and Alterations to Vitamin D Metabolism 2025 ·International Journal of Molecular Sciences ·Teresa Grieco, Giovanni Paolino, Elisa Moliterni, Camilla Chello, Alvise Sernicola, Colin Gerard Egan, Mariangela Morelli, Fabrizio Nannipieri, (unknown), (unknown), (unknown), (unknown), (unknown), Giovanni Pellacani, Stefano Calvieri	0
3	Association between vitamin D receptor polymorphisms, tight junction proteins and clinical features of adult patients with atopic dermatitis 2024 ·Dermatology Practical & Conceptual ·Teresa Grieco, Elisa Moliterni, Giovanni Paolino, Camilla Chello, Alvise Sernicola, Colin Gerard Egan, Fabrizio Nannipieri, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Giovanni Pellacani, Stefano Calvieri	5
4	Differential Expression of Proteins Involved in Skin Barrier Maintenance and Vitamin D Metabolism in Atopic Dermatitis: A Cross-Sectional, Exploratory Study 2024 ·International Journal of Molecular Sciences ·Teresa Grieco, Giovanni Paolino, Elisa Moliterni, Camilla Chello, Alvise Sernicola, Colin Gerard Egan, Mariangela Morelli, Fabrizio Nannipieri, (unknown), (unknown), (unknown), (unknown), (unknown), Giovanni Pellacani, Stefano Calvieri	2
5	P26.14.B VITAMIN D3 ENHANCES TEMOZOLOMIDE EFFICACY IN GLIOBLASTOMA CELLS WHILE PROTECTING NORMAL ASTROCYTES: INVESTIGATING THE EFFECTS OF ADJUNCTIVE THERAPY 2024 ·Neuro-Oncology ·Mariangela Morelli, Francesco Di Lorenzo, Fabrizio Nannipieri, (unknown), (unknown), Francesca Lessi, Chiara Maria Mazzanti	0
6	Association of vitamin D and bisphenol A levels with cardiovascular risk in an elderly Italian population: results from the InCHIANTI study 2024 ·GeroScience ·Maria Luisa Brandi, Francesca Marini, Simone Parri, Stefania Bandinelli, Teresa Iantomasi, Francesca Giusti, (unknown), Giovanna Sini, Fabrizio Nannipieri, (unknown), Giovanni Tripepi, Colin Gerard Egan, Luigi Ferrucci	6
7	Low vitamin D levels predict outcomes of COVID-19 in patients with both severe and non-severe disease at hospitalization 2023 ·Endocrine ·Luigi di Filippo, (unknown), Massimo Locatelli, Fabrizio Nannipieri, Stefano Frara, Andrea Giustina	30
8	Low Vitamin D Levels Are Associated With Long COVID Syndrome in COVID-19 Survivors 2023 ·The Journal of Clinical Endocrinology & Metabolism ·Luigi di Filippo, Stefano Frara, Fabrizio Nannipieri, (unknown), Massimo Locatelli, Patrizia Rovere‐Querini, Andrea Giustina	54
9	Long-term efficacy and safety of neridronate treatment in patients with complex regional pain syndrome type 1: a pre-specified, open-label, extension study 2022 ·Therapeutic Advances in Musculoskeletal Disease ·M. Varenna, Davide Gatti, Francesca Zucchi, Chiara Crotti, V. Braga, Giovanni Iolascon, Bruno Frediani, Fabrizio Nannipieri, Maurizio Rossini	8
10	Effectiveness of a Novel Food Composed of Leucine, Omega-3 Fatty Acids and Probiotic Lactobacillus paracasei PS23 for the Treatment of Sarcopenia in Elderly Subjects: A 2-Month Randomized Double-Blind Placebo-Controlled Trial 2022 ·Nutrients ·Mariangela Rondanelli, Clara Gasparri, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Fabrizio Nannipieri, (unknown), (unknown), Alice Tartara, Simone Perna	35
11	Intramuscular neridronate for the treatment of complex regional pain syndrome type 1: a randomized, double-blind, placebo-controlled study 2021 ·Therapeutic Advances in Musculoskeletal Disease ·M. Varenna, V. Braga, Davide Gatti, Giovanni Iolascon, Bruno Frediani, Francesca Zucchi, Chiara Crotti, Fabrizio Nannipieri, Maurizio Rossini	22
12	Effect of neridronate in osteopenic patients after heart, liver or lung transplant: a multicenter, randomized, double-blind, placebo-controlled study 2021 ·Panminerva Medica ·Sandro Giannini, (unknown), Maria Fusaro, Colin Gerard Egan, Claudio Marcocci, Edda Vignali, Filomena Cetani, Fabrizio Nannipieri, Monica Loy, Antonio Gambino, Giovanni Adami, V. Braga, Maurizio Rossini, Gaetano Paride Arcidiacono, (unknown), Stefania Sella	5
13	Evaluation of the virucidal effect by contact with water-insoluble substances: the case of Xibornol 2017 ·CINECA IRIS Institutial research information system (University of Pisa) ·Marco Verani, Ileana Federigi, (unknown), Fabrizio Nannipieri, (unknown), (unknown), (unknown)	1
14	Phase II trial of intraperitoneal (IP) MHC unrestricted adoptive cell therapy with TALL-104 cells in patients with ovarian carcinoma (OC) with minimal or microscopic residual disease at second look laparotomy/laparoscopy 2015 ·Annals of Oncology ·Pierfranco Conté, (unknown), Fabrizio Nannipieri, Zora Baretta, (unknown), Laura Bonanno, Valentina Guarneri, Giulia Tasca, (unknown), (unknown)	2
15	Double-Blind, Placebo-Controlled, Multiple-Ascending-Dose Study on the Pharmacodynamics of ABIO-08/01, a New CNS Drug with Potential Anxiolytic Activity 2009 ·Neuropsychobiology ·G. Saletu‐Zyhlarz, P. Anderer, Michael Wolzt, Heribert V. Semlitsch, Alessandro Assandri, (unknown), Fabrizio Nannipieri, S Rosini, B. Saletu	3
16	Double-Blind, Placebo-Controlled, Multiple-Ascending-Dose Study on the Pharmacodynamics of ABIO-08/01, a New CNS Drug with Potential Anxiolytic Activity 2009 ·Neuropsychobiology ·B. Saletu, P. Anderer, Michael Wolzt, (unknown), Alessandro Assandri, (unknown), Fabrizio Nannipieri, G. Saletu‐Zyhlarz	2
17	Double‐blind, placebo‐controlled, multiple‐ascending‐dose study on the effects of ABIO‐08/01, a novel anxiolytic drug, on perception and cognition, utilizing event‐related potential mapping and low‐resolution brain electromagnetic tomography 2008 ·Human Psychopharmacology Clinical and Experimental ·P. Anderer, B. Saletu, Michael Wolzt, (unknown), Alessandro Assandri, Fabrizio Nannipieri, S Rosini, G. Saletu‐Zyhlarz	5
18	Short-term intravenous therapy with Neridronate in Paget's disease. 2002 ·PubMed ·Silvano Adami, Maurizio Bevilacqua, M Broggini, Paolo Filipponi, S. Ortolani, E Palummeri, Fabio Massimo Ulivieri, Fabrizio Nannipieri, V. Braga	39
19	Comparison of pharmacokinetic profiles of a 17β-estradiol gel 0.6 mg/g (Gelestra) with a transdermal delivery system (Estraderm TTS 50) in postmenopausal women at steady state 2001 ·Maturitas ·(unknown), (unknown), Fabrizio Nannipieri, (unknown), (unknown)	16
20	Effects of clodronate on synovial fluid levels of some inflammatory mediators, after intra-articular administration to patients with synovitis secondary to knee osteoarthritis. 2001 ·SHILAP Revista de lepidopterología ·Raffaella Cocco, (unknown), Antonella Fioravanti, (unknown), Fabrizio Nannipieri, (unknown), S Rosini, R Marcolongo	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact